Lipoprotein(a) \[Lp(a)\] is a risk factor for cardiovascular events, although the underlying mechanism remains unclear. This study evaluated the relationship between Lp(a) and high-risk attributes (HRA) by coronary computed tomography angiography (CCTA) as well as their prognostic value.
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Association of Lp(a) level with CCTA measured Parameters
Timeframe: at the index procedure
Association of Lp(a) level with CCTA measured Parameters
Timeframe: at the index procedure
Association of Lp(a) level with CCTA measured Parameters
Timeframe: at the index procedure
Association of Lp(a) level with CCTA measured Parameters
Timeframe: at the index procedure
Association of Lp(a) level with CCTA measured Parameters
Timeframe: at the index procedure
Major adverse cardiac events
Timeframe: at 24 months from index procedure